The mechanisms underlying SLE and stroke involve the expression of aPL (a common SLE antibody) on endothelial surfaces, which leads to the release of pro-inflammatory cytokines and the upregulation of adhesion molecules [34]. This evidence concerns the gene FASLG and systemic lupus erythematosus.